Please login to the form below

Not currently logged in
Email:
Password:

Zealand announces management changes

Firm making the roles of chief scientific officer and chief operating officer redundant

Zealand Pharma is set to make a series of restructuring changes that will shake-up a number of positions at the firm.  

The R&D arm of Zealand will be split into two parts, each with direct representation in management, while investor relations and communications will also be represented directly at management level.

As a result of the restructuring, the former positions of chief scientific officer and chief operating officer have become redundant.

Adam Steensberg, VP for development, has been promoted and appointed to the new position as senior VP for development and chief medical officer. 

The new position as senior VP for research will temporarily be filled by Keld Fosgerau, currently VP for research, while the company searches for a permanent appointment. 

Hanne Leth Hillman, VP for investor relations and corporate communications is promoted, and appointed to the new position as senior VP for investor relations and communications.

The reorganisation aims to “eliminate one management level in support of the company's strategy” and to “ensure a dynamic organisation with operational flexibility and short decision-making”.

Britt Meelby Jensen, president and CEO of Zealand, said: “I wish Adam, Keld and Hanne every success in their new roles and I look forward to working with them in their new roles.”

Article by
Ben Adams

20th March 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...